Cargando…

Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?

PURPOSE: The purpose of this study is to evaluate the efficacy of hypofractionated radiation therapy (RT) in the treatment of unresectable hepatocellular carcinoma (HCC) after failure of transarterial chemoembolization (TACE) or in cases of refractory HCC, and to investigate biliary complications af...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jeong Il, Park, Hee Chul, Lim, Do Hoon, Paik, Seung Woon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843719/ https://www.ncbi.nlm.nih.gov/pubmed/26194367 http://dx.doi.org/10.4143/crt.2015.076

Ejemplares similares

Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
por: Yoo, Gyu Sang, et al.
Publicado: (2020)

Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma
por: Kim, Young Il, et al.
Publicado: (2012)

Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
por: Yu, Jeong Il, et al.
Publicado: (2011)

Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2012)

Treatment outcome of hepatic re-irradiation in patients with hepatocellular carcinoma
por: Seol, Seung Won, et al.
Publicado: (2015)

Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma
por: Kim, Sang Won, et al.
Publicado: (2014)

Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
por: Oh, Dongryul, et al.
Publicado: (2015)

Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2019)

The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma
por: Shen, Jie, et al.
Publicado: (2021)

Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Ji-Yoon, et al.
Publicado: (2013)

Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2020)

Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?
por: Lee, Kyung Hwa, et al.
Publicado: (2018)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

Successful Treatment of Stereotactic Body Radiation Therapy Combined with Transarterial Chemolipiodolization for Hepatocellular Carcinoma with Biliary Obstruction
por: Park, Chan-Kwon, et al.
Publicado: (2011)

Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
por: Kim, Nalee, et al.
Publicado: (2023)

Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area
por: Yu, Jeong Il, et al.
Publicado: (2017)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2018)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma
por: Ide, Ryuta, et al.
Publicado: (2017)

Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
por: Goh, Myung Ji, et al.
Publicado: (2023)

Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
por: Ha, Sang Yun, et al.
Publicado: (2019)

Safety and efficacy of 10-fraction hypofractionated radiation therapy for non-small cell lung cancer
por: Yoo, Ye Jin, et al.
Publicado: (2021)

Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
por: Park, Jongmoo, et al.
Publicado: (2018)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Magnetic Resonance Image-Guided Hypofractionated Ablative Radiation Therapy for Hepatocellular Carcinoma With Tumor Thrombus Extending to the Right Atrium
por: Dincer, Neris, et al.
Publicado: (2022)

Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
por: Lee, Eonju, et al.
Publicado: (2015)

Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)

Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
por: Yu, Jeong Il, et al.
Publicado: (2017)

Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases
por: Jo, In-Young, et al.
Publicado: (2014)

Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017
por: Bae, Bong Kyung, et al.
Publicado: (2023)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

Long-term Results of Percutaneous Ethanol Injection for the Treatment of Hepatocellular Carcinoma in Korea
por: Sung, Yon Mi, et al.
Publicado: (2006)

Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice
por: Kim, Nalee, et al.
Publicado: (2023)

Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma
por: Shiba, Shintaro, et al.
Publicado: (2020)

Acute Pancreatitis Complicating Pregnancy in a Patient with Co-Existing Choledochal Cyst
por: Son, Hee Jung, et al.
Publicado: (1997)

Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice
por: Woo, Hyun Young, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2mdlscqd8mp2gttt51psld1pub